14.03.2016 - 16.03.2016
Immuno-Oncology (14-15 March) will focus on innovations and progress in harnessing the body’s immune response to attack cancer and on overcoming inhibitory factors that prevent this.
Further exciting and innovative advances in cancer research are presented in Novel Approaches for Cancer (15-16 March) which covers engineering and development for bispecifics, ADCs, and fusion proteins. This event continues the strong focus on immune-response enhancing technologies. Data-rich presentations include platform development, engineering challenges, and technologies for target and lead selection, and cover measures to enhance potency, stability and resistance to aggregation. These studies cover early development through to pre-clinical evaluation.
Contact: Cambridge Healthtech Institute CHI